Literature DB >> 12653711

The role of free oxygen radicals in the aetiopathogenesis of rosacea.

M O Oztas1, M Balk, E Ogüs, M Bozkurt, I H Ogüs, N Ozer.   

Abstract

A possible link between superoxide dismutase activity and malondialdehyde level with the clinical manifestations of rosacea was investigated. We found differences in superoxide dismutase activities between mild rosacea (stages I and II) and severe involvement (stage III) groups, as well as between disease and control groups that were statistically significant (P < 0.05). In the mild involvement group (stages I and II), the superoxide dismutase activity was higher than in the control group (P < 0.05), while the malondialdehyde levels did not differ from the control. In the severe involvement group (stage III), the superoxide dismutase activity was lower than in the control group (P < 0.05), and this was coupled to a raised level of malondialdehyde (P < 0.05). These findings clearly show that in the mild involvement phase of rosacea patients, superoxide dismutase activity was stimulated to protect the skin against reactive oxygen species so that the malondialdehyde levels were maintained. In contrast, in more severe disease, due to a decrease in the capacity of the antioxidant defence system, the malondialdehyde levels were increased. These findings support the 'antioxidant system defect hypothesis' in rosacea patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653711     DOI: 10.1046/j.1365-2230.2003.01179.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  11 in total

Review 1.  [Rosacea. Clinical features, pathogenesis and therapy].

Authors:  P Lehmann
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751

2.  Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

3.  Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2012-03

4.  Rosacea, reactive oxygen species, and azelaic Acid.

Authors:  David A Jones
Journal:  J Clin Aesthet Dermatol       Date:  2009-01

5.  Relationships of Serum Homocysteine, Vitamin B12, and Folic Acid Levels with Papulopustular Rosacea Severity: A Case-Control Study.

Authors:  Bo Young Chung; Hye One Kim; Chun Wook Park; Na Gyeong Yang; Jae Yun Kim; Yun Su Eun; Euy Hyun Chung; Sung Yul Lee; Young Lip Park; Sang Hoon Lee; Nam Hun Heo; Min Jeong Shin; Jung Eun Kim
Journal:  Biomed Res Int       Date:  2022-07-04       Impact factor: 3.246

Review 6.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

Review 7.  Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition.

Authors:  Yu Ri Woo; Ji Hong Lim; Dae Ho Cho; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2016-09-15       Impact factor: 5.923

8.  Oxidative stress in patients with acne vulgaris.

Authors:  Ozer Arican; Ergul Belge Kurutas; Sezai Sasmaz
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

9.  Increased risk of chronic kidney disease in patients with rosacea: A nationwide population-based matched cohort study.

Authors:  Hsien-Yi Chiu; Wen-Yen Huang; Chung-Han Ho; Jhi-Joung Wang; Sung-Jan Lin; Ya-Wen Hsu; Ping-Jen Chen
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

10.  Oxidative stress in patients with endemic pemphigus foliaceus and healthy subjects with anti-desmoglein 1 antibodies.

Authors:  Ericson Leonardo Gutierrez; Willy Ramos; Lucia Seminario-Vidal; Mercedes Tello; Gerardo Ronceros; Alex G Ortega-Loayza
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.